Polarized Light Microscopy Digital Image Gallery

DDI (2',3'-Dideoxyinosine)

DDI is a synthetic purine nucleoside that acts as a reverse transcriptase inhibitor. As such, the drug may prevent further reproduction of HIV viral cells, but does not affect existing cells. Studies indicate that DDI may also cause an increase in the number of CD4 helper white blood cells in the body, functioning to counteract the depressed counts associated with advanced stages of HIV. However, due to the severe nature of some side effects associated with the drug, when the United States Food and Drug Administration (FDA) initially approved DDI for the treatment of HIV/AIDS in 1991, it was designated solely for use after prolonged AZT treatments. Yet, in recent years, the FDA has approved DDI as a vanguard therapy that can be utilized early on in HIV/AIDS treatments.

© 1995-2019 by Michael W. Davidson and The Florida State University. All Rights Reserved. No images, graphics, software, scripts, or applets may be reproduced or used in any manner without permission from the copyright holders. Use of this website means you agree to all of the Legal Terms and Conditions set forth by the owners.
This website is maintained by our
Graphics & Web Programming Team
in collaboration with Optical Microscopy at the
National High Magnetic Field Laboratory.
Last modification: Thursday, Nov 20, 2003 at 02:51 PM
Access Count Since November 20, 2003: 6794
Microscopes provided by:
Visit the Nikon website. Visit the Olympus Microscopy Resource Center website.